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Diagnostic yield from flexible bronchoscopy in the absence of visible endobronchial abnormality varies, ranging 20-84% for malignant parenchymal lesions and 35-56% for benign lesions. [2] [3] [4] [5] [6] The diagnostic yield of bronchoscopy is particularly low in lesions ≤2 cm that are located in the outer third of the lung, [2, 4] while computed tomography (CT)-guided transthoracic needle aspiration (TTNA) biopsy may provide more accurate diagnosis of the peripheral lung lesions. However, high risk of pneumothorax, ranging 23%-44%, is the limitation of TTNA biopsy. [7] [8] [9] [10] In addition to TTNA biopsy, surgical biopsy via video-assisted thoracoscopic surgery (VATS) and thoracotomy are other invasive techniques for the diagnosis of the peripheral lung lesions. Thus, alternative diagnostic approaches are necessary in this situation. We therefore used the combination of electromagnetic navigation bronchoscopy (ENB) and radial endobronchial ultrasound (r-EBUS) with the assumption that this approach would increase the diagnostic yield for peripheral lung lesions while decreasing the complication rate.
MATERIALS AND METHODS

Patients
This study conforms to the principles outlined in the Declaration of Helsinki. The local Ethics Committee approved the study. Fifty-six patients who were admitted to the Yedikule Chest Diseases and Thoracic Surgery Education and Research Hospital, the largest tertiary interventional pulmonology center in Turkey, were included in the study. Subjects who were candidates for nonemergency bronchoscopy and aged over 18 years with peripheral lung lesions or solitary pulmonary nodules without any visible endobronchial lesion by bronchoscopy, were included. The present study excluded any subject who could not tolerate conscious sedation or a flexible bronchoscopy procedure. All the patients were discussed in a multidisciplinary meeting, where a thoracic surgeon, an interventional pulmonologist, and an interventional radiologist were available, and the bronchoscopic approach was decided as a safer option over surgical biopsy or computed tomography (CT)-guided TTNA due to underlying comorbidities, poor pulmonary function tests, or severe bullous changes on CT scan.
Bronchoscopy
Flexible bronchoscopy (BF-XP 160, Olympus, Tokyo, Japan) was performed with topical anesthesia and intravenous (IV) sedation. Topical anesthesia was achieved by applying two puffs of 10% lidocaine to the oropharyngeal mucosa of each spontaneously breathing patient. The patients were premedicated with IV midazolam 2-5 mg. Patient monitoring consisted of continuous finger pulse oximetry and electrocardiography.
Electromagnetic navigation procedure An 
EWC (Extended working channel): A sensor probe or
flexible foceps or brush is deployed to the target lesion through this EWC, which is 130 mm in length and 1.9 mm in diameter. 4. The computer software and monitor: This system enables the bronchoscopist to view the reconstructed three-dimensional CT scans of the object's anatomy into multiplanar, including coronal, sagittal, and axial, views together with superimposed graphic information depicting the position of the sensor probe-allowing the bronchoscopist real-time navigation to biopsy endobronchially invisible lesions through the EWC. [11] [12] [13] All patients had multislice CT scans of the chest done, with a slice thickness of 1 mm and interval of 0.8 mm. The digitized information from each patient's CT scan was imported into the electromagnetic navigation system in which multislice views of the chest and virtual bronchoscopy images were reconstructed. The target points, which are anatomic landmarks, including the main carina, right and left upper lobe carina, middle lob carina, and left lower lobe carina, were identified and thus radiological mapping was completed; these data points were then loaded to the electromagnetic navigation system. The navigation error is the closest distance between the sensor probe and the lesion center.
The patients were placed on supine position on the localization board. Three reference electrodes were placed on the anterior chest. The anatomic landmarks, such as carina of the lobes in both right and left lung, are touched with the sensor probe during bronchoscopic examination called endobronchial mapping. When these points were touched with the sensor, they were simultaneously recorded by the navigation system. The system software correlated data obtained during radiological mapping with data obtained during real-time bronchoscopy mapping, providing a registration error. Afterward, flexible bronchoscopy was done with the sensor on its tip pointed toward the target [ Figure 1 ]. When the sensor probe was in relation to the nearest part of the target lesion, the EWC was mechanically locked. Transbronchial forceps biopsy, brushing, and bronchoalveolar lavage were performed in all subjects. Rapid onsite cytopathologic examination was not available for any of the patients. All patients had chest x-rays done after the procedure to rule out pneumothroax.
If the ENB-guided biopsy provided a definitive histolopathologic diagnosis, this was marked as diagnostic success by ENB. If the result of the ENB-guided biopsy was nondiagnostic, then other procedures, such as CT-guided TTNA biopsy or surgery, were perfor med to achieve a definitive diagnosis. If both procedures failed to reveal a definitive diagnosis, these cases were also considered as diagnostic success for ENB. However, if an ENBguided biopsy provided a negative diagnosis and the subjects were unable or unwilling to undertake further diagnostic testing, clinical and radiologic follow-up was used to observe stability (range 6-24 months). If the lesions remained stable radiologically, then the negative result of ENB-guided biopsy was marked as a diagnostic success. Diagnosis made by TTNA biopsy or by surgery other than the ENB-guided biopsy was considered to be ENB failure.
Combined electromagnetic navigation bronchoscopy and electromagnetic navigation bronchoscopy
r-EBUS was used to confirm the target lesion location after the lesion was navigated by ENB in 26 of 56 patients (UM-BS20-26R, 20 MHz, Olympus, Tokyo, Japan). Once the lesion was located by ENB, the sensor probe was withdrawn and the r-EBUS probe (outer diameter 2.0 mm, length 850 mm) was inserted through the EWC. Normal air-filled alveolar tissue typically produces a "snowstorm-like" appearance. However, solid lesions are seen as darker and more homogeneous [ Figure 2 ]. When such images were captured, the probe was considered to be located within or adjacent to the target lesion. The probe was then removed and biopsies were performed with disposable forceps. However, if no acceptable EBUS image was obtained, renavigation with ENB and subsequent reconfirmation with EBUS was attempted before biopsies were taken.
Specimens
Transbronchial biopsy specimens were collected into a formalin-filled cup for permanent surgical pathologic examination, while material obtained by brush and bronchoalveolar lavage were split for cytologic and microbiologic examinations.
Statistical analysis
The statistical analysis was made with the use of a commercially available statistical package, SPSS for Windows, Version 15.0 (IBM SPSS for Windows, Table 1 ].
The diagnostic yield of ENB-guided biopsy was increased as the lesion size increased but it did not reach a statistically significant level (P = 0.065) [ Table 2 ]. When the lesions were analyzed by lobar distribution, there was a trend of the highest ENB yield in lesions being located in the right middle lobe (100%) and the lowest yield in the left upper lobe (56.2%), but because of the small sample size, this did not reach statistical significance (P = 0.59) [ Table 3 ].
The diagnostic yield in the ENB-only group was 71.42%. The sensitivity, specificity, positive predictive value, and negative predictive value for malignant diseases were 62%, 100%, 100%, and 47%, respectively. The sensitivity, specificity, positive predictive value, and negative predictive value for benign disease were 100%, 62%, 47%, and 100%, respectively. In the group where ENB and r-EBUS were used, with 26 of the 56 (46.4%) patients, the diagnostic yield was 73.07%. The analysis of patients who had a positive diagnostic yield compared to a negative diagnostic yield showed no significant differences in registration error or navigation error. However, 11 of the 14 cases whose navigation error was below 5 mm had positive definitive diagnosis by ENB with the dianostic yield of 78.5%. Pneumothorax occurred in only 1 (1.7%) of the patients, who was treated with tube thoracostomy.
DISCUSSION
There is an increasing need for minimally invasive diagnostic procedures that would provide higher diagnostic yield for peripheral lung lesions. In addition, the patients in whom the conventional bronchoscopy is nondiagnostic are usually referred for more invasive procedures, such as CT-guided TTNA biopsy or surgical biopsy. Both of these procedures are associated with higher costs and greater risk of complications. [14] [15] [16] Identification of peripheral lung lesions using less invasive methods will decrease the necessity of surgical resection.
In a retrospective analysis, Hoffmann and Dienemann [17] reported that approximately 50% of the parenchymal lesions were benign. Radke et al. [18] showed that the number of benign lesions observed in screening programs exceeded 90%. ENB is a novel technique to help the diagnosis of endobronchially invisible lesions. In general, the diagnostic yield of ENBguided biopsy of peripheral lung lesions has not exceeded 76% (range 62-76%) in the literature. [11, [19] [20] [21] [22] In a comparison study of r-EBUS and ENB, it has been shown that the two procedures used in combination provided a higher diagnostic yield in the sampling of peripheral lung lesions; 69% in only r-EBUS, 59% in only ENB sampling, and 88% in the combination of two procedures. [23] The present study has shown minimal increase in the diagnostic yield of peripheral lung lesions when r-EBUS was combined with ENB. The diagnostic accuracy in the only-ENB group was 71.4%, while it was 73% in the combined group. It is likely that due to a small sample size, this increase in diagnostic yield is not statistically significant.
In the present study, the diagnostic yield from ENB was independent of lesion size, lesion location, and technical issues, including registration or navigation error, similar to previously reported studies. [11, 12, 21, 24] However, navigation error was shown to affect the diagnostic yield in one study by Makris et al. at the point of ≤4 mm. The overall diagnostic yield was 62.5% and increased to 77.2% if the navigation error was ≤4 mm. [19] Our study showed that the diagnostic yield increased from 71.4% to 78.5% if the navigation error was <5 mm, but this was not statistically significant. On the other hand, although diagnostic yield was independent of the size of the peripheral lesion in our study, the tendency was observed that diagnostic yield by ENB increased as the size of peripheral lesions increased, which was not statistically significant. In addition, although the diagnostic yield of the present study was independent of lobar distribution, the right middle lobe had a better yield compared to the other lobes. The highest diagnostic yield and lowest diagnostic yield of the present study were in the right middle lobe (100%) and left upper lobe (56.2%), respectively. The higher yield in the right middle lobe and lower yield of the upper lobes may be attributed to the tendency for sharper angles in the upper lobes in the bronchial tree, making it a challenge to navigate even with a steerable sensor probe. On the other hand, navigation in the lower lobes is also affected by the movement of the diaphragm during respiration, leading to errors. [22] The diagnostic yield of ENB is influenced by several factors. CT-to-body divergence is a more important factor than the size or location of the lesion. The divergence between the data obtained preoperatively by CT and data obtained during bronchoscopy, called CT-to-body divergence, provides a measure of the accuracy of ENB.
Rapid onsite cytological evaluation (ROSE) with ENB has been previously used in a limited number of studies. [20, [25] [26] [27] [28] It was proposed that studies using ENB combined with general anesthesia or ROSE had significantly better yields, which was strongly expected but is yet to be proven. [29] Moreover, the exact effect of ROSE on the performance of ENB bronchoscopy has not been assessed in large randomized clinical trials. The effect of general anesthesia was evaluated in two trials, without sufficient statistical power to reach a significant conclusion [12, 23, 29] The pneumothorax incidence rate of the ENB procedure (1.7%) was similar to the previously published reports in the present study, suggesting the safety of ENB for peripheral lung lesions. [21, 24, 26] ENB, positron emission tomography (PET)/CT, and rapid onsite cytopathologic examination are efficient and reliable methods when combined for the diagnosis of peripheral lung lesions. This combination prevents insufficient sampling of peripheral lung lesions. Lamprecht et al. showed that the diagnostic yield of this combination of methods was 76.9% in peripheral lung lesions. [20] Eberhardt et al. compared forceps biopsy using the suction catheter with ENB-guided biopsy of peripheral lung lesion and found an improved diagnostic yield with forceps biopsy. [21] The diagnostic yield of peripheral lung lesion sampling by needle aspiration rather than by transbronchial biopsy was also supported in the study by Reichenberg et al. [30] ENB has also been used in studies for treatment of lung cancer. The CyberKnife Robotic Radiosurgery System (Accuracy Inc, Sunnyvale, CA, USA) stereotactic body radiosurgery has been considered as a curative option for medically inoperable Stage I lung cancer patients who have severe chronic obstructive lung disease or advanced cardiovascular diseases. ENB provides a safer method for placement of fiducial markers in or near the intraparenchymal tumors. Schroeder et al. showed that 52 consecutive inoperable patients with isolated lung tumors underwent fiducial placement using ENB without any migration. [31] ENB can also be used in some inoperable lung tumor patients in such a manner that chemotherapy, endoluminal high-dose brachytherapy, or local radiotherapy can be directed into the peripheral lung lesions. [32] Becker et al. applied this endoluminal brachytherapy technique with a palliative intent in a feasibility study, and observed a complete remission in 5 out of 9 patients treated.
Becker et al. have achieved complete remission in all 8 patients treated with curative intent to date. [33] The present study has a higher number of patients than the other studies summarized in Table 4 and has similar and confirmatory diagnostic yield compared to the literature. However, there are some limitations. It is likely that because of the small size of comparison groups, comparing ENB alone and r-EBUS with ENB, there was no statistical significance in terms of diagnostic yield as opposed to other studies. The second limitation is that we did not have a separate, third group with r-EBUS to compare this modality alone to ENB and ENB plus r-EBUS. The third limitation is that the present study is not a prospective randomized controlled trial for the combinative model of EBUS with ENB for the peripheral lung lesions, leading to the low yield in the EBUS combinative model. Finally, the present study had a variable follow up period for cases of negative biopsy with ENB guidance at first attempt that we considered ENB as successful even though a minimum of a 6-months follow up may not be enough to determine if the lesion is benign or stable.
CONCLUSION
In conclusion, ENB with or without r-EBUS is a safe, efficient, and easily applied method for sampling of peripheral lung lesions with high diagnostic yield independent of lesion size, lesion lobar location, and registration or navigation error.
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